The Toxicity of Radiotherapy Following High-dose Chemotherapy With Peripheral Blood Stem Cell Support in High-risk Breast Cancer: A Preliminary Analysis

Author： van der Wall E.   Schaake-Koning C.C.E.   van Zandwijk N.   Baars J.W.   Schornagel J.H.   Richel D.J.   Rutgers E.J.T.   Borger J.H.   Beijnen J.H.   Rodenhuis S.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.9, 1996-08, pp. : 1490-1497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

By Haas R.   Schmid H.   Hahn U.   Hohaus S.   Goldschmidt H.   Murea S.   Kaufmann M.   Wannenmacher M.   Wallwiener D.   Bastert G.   Hunstein W.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 372-378

Elsevier

Access to resources Recommend Favorite

High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers

By Yeh K-H.   Lin M-T.   Lin D-T.   Tang J-L.   Lui L-T.   Lin J-F.   Chang Y-S.   Cheng A-L.   Yu S-C.   Chang K-J.   Chen Y-C.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 237-244

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma

By Engelhardt M.   Zeiser R.   Ihorst G.   Finke J.   Müller C.  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 1, 2007-01 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

By Svane Inge M.   Homburg Keld M.   Kamby Claus   Nielsen Dorte L.   Roer Ole   Sliffsgaard Dorte   Johnsen Hans E.   Hansen Steen W.  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Hematologic Toxicity of Salvage Chemotherapy Following Stem Cell-Supported High-Dose Chemotherapy in Women with Recurrent Ovarian Cancer

By Cook S.   Penson R.   Duska L.   Nikrui N.   Goodman A.   Fuller A.   Seiden M.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 48-54

Elsevier

Access to resources Recommend Favorite